Treatment of ischemic cerebrovascular diseases: the comparative studies between fluorocarbon blood substitute (FCBS) and low molecular weight dextran (LMWD)

Biomater Artif Cells Artif Organs. 1988;16(1-3):617-8. doi: 10.3109/10731198809132616.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Blood Substitutes*
  • Brain Ischemia / physiopathology
  • Brain Ischemia / therapy*
  • Cerebrovascular Circulation
  • Dextrans / therapeutic use*
  • Fluorocarbons / adverse effects
  • Fluorocarbons / therapeutic use*
  • Humans
  • Oxygen / administration & dosage
  • Oxygen / therapeutic use

Substances

  • Blood Substitutes
  • Dextrans
  • Fluorocarbons
  • Oxygen